Hoffmann is currently chairman of Biotest AG, sits on the board of directors of European biotechnology company Genmab AG, and is a director of San Francisco-based Trigemina Inc.
He has served in a number of senior roles in the pharmaceutical industry, most recently 12 years with Amgen as senior vice president of commercial operations for the US, and before that for SVP International and Europe.
He started his pharmaceutical career at Eli Lilly as a sales representative, and progressed to a number of senior positions, including president, Latin America and general manager in Germany and South Africa.
Hoffman holds an MBA from the University of North Carolina, a Master's degree from the University of Cologne, and is Adjunct Professor at UNC Kenan-Flagler Business School.
EUSA Pharma focuses on oncology and oncology supportive care. The company has commercial operations in the US and Europe, and a wider distribution network in approximately 40 countries around the world.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer